Bull Run

India's AI-powered stock screener for NSE & BSE. 5,000+ stocks with fundamentals and real-time analysis.

info@bullrun.co.in

Navigate

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist
  • Go Premium

Tools

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog

Indices

  • All Indices
  • Nifty 50 Stocks
  • Sensex Stocks
  • Nifty Bank
  • Nifty IT
  • Nifty Pharma
  • Nifty Midcap 100

Screeners

  • Top Dividend Stocks
  • Debt Free Stocks
  • Undervalued Stocks
  • High ROE Stocks
  • Low PE Stocks
  • Top Rated Stocks
  • Large Cap Stocks
  • Compare Stocks
  • Browse by Sector

Browse Stocks by Sector

View All →
Non Banking Financial Company (NBFC)PharmaceuticalsComputers - Software & ConsultingIndustrial ProductsCivil ConstructionAuto Components & EquipmentsSpecialty ChemicalsOther Financial ServicesIT Enabled ServicesPackagingHotels & ResortsCommodity ChemicalsOther Electrical EquipmentGarments & ApparelsPaper & Paper ProductsSoftware ProductsPackaged FoodsCement & Cement ProductsSugarHeavy Electrical EquipmentHospitalEdible OilPower GenerationHealthcare Service Provider
© 2026 Bull Run. All rights reserved.
AboutBlogPrivacy PolicyTerms of Service

Disclaimer: Ratings and scores are generated algorithmically from publicly available market data for educational and informational purposes only. They do not constitute investment advice or solicitation to buy/sell securities. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.

  1. Home
  2. /
  3. Sectors
  4. /
  5. Healthcare Research, Analytics & Technology
  6. /
  7. Take Solutions Ltd
Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
HomeStocksHealthcare Research, Analytics & TechnologyTake Solutions Ltd

Take Solutions Ltd Stock Price Today (NSE: TAKE)

Take Solutions Ltd

TAKEHealthcare Research, Analytics & Technology
₹39.62+₹0.76 (+2.00%)↑
As on 30 Mar 2026, 12:01 pm ISTMarket Closed

Fundamental Score

...

Take Solutions Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Take Solutions Ltd share price today is ₹39.62, up +2.00% on NSE/BSE as of 30 March 2026. Take Solutions Ltd (TAKE) is a Small-cap company in the Healthcare Research, Analytics & Technology sector with a market capitalisation of ₹481.24 (Cr). The 52-week high for TAKE share price is ₹49.94 and the 52-week low is ₹6.51. At a P/E ratio of 120.61x, TAKE is currently trading above its industry average P/E of 45.95x. The company has a Return on Equity (ROE) of 644.12% and a debt-to-equity ratio of 0.00.

Take Solutions Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
+2.00%

Returns & Performance

Excellent

ROE

644.12%
Poor

ROCE

11.24%
Poor

OPM (5Y)

-6.48%

Div Yield

0.00%

Take Solutions Ltd Valuation Check

Poor

P/E Ratio

120.61x
Poor

Industry P/E

45.95x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

481.24 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

53.33%

Sales Growth (Q)

N/A

Sales Growth (5Y)

N/A
Excellent

EPS Growth (5Y)

38.14%
Excellent

Profit Growth (5Y)

38.14%

Balance Sheet Health

Excellent

Debt to Equity

0.00x
Excellent

Int. Coverage

4.14x

Free Cash Flow (5Y)

105.14 (Cr)

Shareholding

Average

Promoter

5.19%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Take Solutions Share Price: A Financial Stability Analysis

In the rapidly evolving landscape of healthcare research, analytics, and technology, companies face the constant pressure to innovate and adapt. This financial analysis delves into the stability of Take Solutions Ltd, specifically examining the current Take Solutions share price of ₹43.27, along with key financial ratios, to assess its performance within the sector. This evaluation is part of an extensive 80-parameter fundamental audit, verified by Sweta Mishra, aimed at understanding the company's long-term viability.

The reported Price-to-Earnings (PE) ratio of 120.61 for Take Solutions Ltd. suggests that the market has high expectations for its future earnings growth. However, this relatively high PE should be considered in conjunction with other factors. Comparing Take Solutions Ltd. to peers like NOVELIX PHARMACEUTICALS LIMITE, one can observe differences in management quality reflected in their strategic decisions and operational efficiency. A thorough comparative analysis of management commentary and historical performance is crucial for a more informed perspective. While we are not drawing direct parallels, such comparisons highlight the importance of qualitative factors in assessing financial health.

Return on Capital Employed (ROCE) for Take Solutions Ltd. is currently reported at 11.24%. ROCE indicates the profitability of a company relative to its capital employed. This figure can be a significant factor influencing the company's "moat" – its competitive advantage. A higher ROCE generally indicates a stronger ability to generate profits from invested capital, which can be reinvested to fuel further growth and solidify its market position. However, maintaining and improving this ROCE requires continuous innovation and efficient capital allocation.

It's important to note that this analysis is based on publicly available data and is for informational purposes only. It should not be considered as financial advice. Further due diligence and consultation with a qualified financial advisor are recommended before making any investment decisions. This analysis observes trends and relationships without offering any buy or sell recommendations on Take Solutions Ltd. or any of its peers.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Take Solutions Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TAKE across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Return on Equity (644.12%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Robust Profit Growth (53.33%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Excellent EPS Growth (38.14% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (38.14% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Cash Generation (₹105.14 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Margin Pressure Concerns (-6.48%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 120.61x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Low Promoter Commitment (5.19%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Take Solutions Ltd Financial Statements

Comprehensive financial data for Take Solutions Ltd including income statement, balance sheet and cash flow

About TAKE (Take Solutions Ltd)

Take Solutions Ltd is a global technology company at the forefront of healthcare research, analytics, and technology. They are a dynamic force driving innovation across the healthc...are ecosystem. Specializing in intricate data analysis and technological solutions, TAKE empowers healthcare organizations to unlock valuable insights, optimize processes, and improve patient outcomes. Their commitment extends beyond simply offering services; it's about partnering with clients to navigate the ever-evolving landscape of healthcare, leveraging advanced analytics and cutting-edge technology to pave the way for meaningful advancements. Take Solutions works to transform data into actionable knowledge. TAKE provides an array of specialized services designed to address the unique challenges within the life sciences and healthcare sectors. Their expertise encompasses a broad spectrum, including clinical research support, advanced analytics for drug development, and solutions for regulatory compliance. They delve deep into healthcare data to identify trends, predict outcomes, and enhance the efficiency of research and development processes. This in-depth approach enables clients to make informed decisions, accelerate innovation, and ensure the highest standards of quality and safety in the development and delivery of healthcare products and services. TAKE's holistic approach leverages digital transformation and mobile solutions, improving the patient experience while generating payer insights. They are dedicated to pushing the boundaries of what's possible in healthcare, working with clients to create a healthier future for all. Their solutions are meticulously crafted to meet the specific needs of each client, ensuring that they receive customized support and achieve optimal results. With a focus on innovation, collaboration, and a commitment to excellence, TAKE Solutions Ltd is a driving force in the transformation of the healthcare industry.

Company Details

Symbol:TAKE
Industry:Healthcare Research, Analytics & Technology
Sector:Healthcare Research, Analytics & Technology
Website:https://www.takesolutions.com

Key Leadership

Mr. Vedamirtham Venkatesan
CFO & Whole Time Director
Mr. Srinivasan Ramani Harikesavanallur
Non-Executive Director
Ms. Sonia Bhimrajka
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date
2019-08-01

Latest News

Indian equities scale record peaks, but end flat as profit-taking sets in - Reuters
Reuters• 11/27/2025
ABB India falls as higher costs, fewer orders take bite out of profit - TradingView — Track All Markets
TradingView — Track All Markets• 11/6/2025
Is the Indian stock market closed today for Diwali 2025? - livemint.com
livemint.com• 10/20/2025

TAKE Share Price: Frequently Asked Questions

What is the current share price of Take Solutions Ltd (TAKE)?

As of 30 Mar 2026, 12:01 pm IST, Take Solutions Ltd share price is ₹39.62. The TAKE stock has a market capitalisation of ₹481.24 (Cr) on NSE/BSE.

Is TAKE share price Overvalued or Undervalued?

TAKE share price is currently trading at a P/E ratio of 120.61x, compared to the industry average of 45.95x. Based on this relative valuation, the Take Solutions Ltd stock appears to be Overvalued against its sector peers.

What is the 52-week high and low of TAKE share price?

The 52-week high of TAKE share price is ₹49.94 and the 52-week low is ₹6.51. These values are updated daily from NSE/BSE price data.

What factors affect the Take Solutions Ltd share price?

Key factors influencing TAKE share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Take Solutions Ltd a good stock for long-term investment?

Take Solutions Ltd shows a 5-year Profit Growth of 38.14% and an ROE of 644.12%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in TAKE shares.

How does Take Solutions Ltd compare with its industry peers?

Take Solutions Ltd competes with major peers in the Healthcare Research, Analytics & Technology. Investors should compare TAKE share price P/E of 120.61x and ROE of 644.12% against the industry averages to determine competitive standing.

What is the P/E ratio of TAKE and what does it mean?

TAKE share price has a P/E ratio of 120.61x compared to the industry average of 45.95x. Investors pay ₹121 for every ₹1 of annual earnings.

How is TAKE performing according to Bull Run's analysis?

TAKE has a Bull Run fundamental score of 19.5/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does TAKE belong to?

TAKE operates in the Healthcare Research, Analytics & Technology industry. This classification helps understand the competitive landscape and sector-specific trends affecting Take Solutions Ltd share price.

What is Return on Equity (ROE) and why is it important for TAKE?

TAKE has an ROE of 644.12%, which indicates excellent management efficiency. ROE measures how efficiently Take Solutions Ltd generates profits from shareholders capital.

How is TAKE debt-to-equity ratio and what does it indicate?

TAKE has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.

What is TAKE dividend yield and is it a good dividend stock?

TAKE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Take Solutions Ltd shares.

How has TAKE share price grown over the past 5 years?

TAKE has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 38.14%, and EPS Growth 38.14%.

What is the promoter holding in TAKE and why does it matter?

Promoters hold 5.19% of TAKE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Take Solutions Ltd.

What is TAKE market capitalisation category?

TAKE has a market capitalisation of ₹481 crores, placing it in the Small-cap category.

How volatile is TAKE stock?

TAKE has a beta of N/A. A beta > 1 suggests the Take Solutions Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is TAKE operating profit margin trend?

TAKE has a 5-year average Operating Profit Margin (OPM) of -6.48%, indicating the company's operational efficiency.

How is TAKE quarterly performance?

Recent quarterly performance shows Take Solutions Ltd YoY Sales Growth of N/A% and YoY Profit Growth of 53.33%.

What is the institutional holding pattern in TAKE?

TAKE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Take Solutions Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Take Solutions Ltd

What is the current share price of Take Solutions Ltd?

Take Solutions Ltd (TAKE) trades at ₹39.62 on NSE and BSE. Market cap ₹481.24 (Cr). Educational data only.

What is the P/E ratio of Take Solutions Ltd?

Take Solutions Ltd has a P/E of 120.61x vs industry average 45.95x.

What is the Bull Run score for Take Solutions Ltd?

Take Solutions Ltd has a Bull Run score of 19.5/100 based on 25+ financial parameters.

Does Take Solutions Ltd pay dividends?

Take Solutions Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Take Solutions Ltd?

Take Solutions Ltd has ROE of 644.12%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Take Solutions Ltd?

Take Solutions Ltd has debt-to-equity of 0.00.

Is Take Solutions Ltd a good investment?

Bull Run gives Take Solutions Ltd a score of 19.5/100. This is not investment advice — consult a SEBI-registered advisor.